IRVINE, Calif., December 22, 2021–(BUSINESS WIRE)–Enevate, a pioneering battery innovation company featuring extreme fast charge and high energy density battery technologies for electric vehicles (EVs) and other markets, met and exceeded its goals for 2021.
"I am extremely proud of the achievements of our team during this past year as we successfully executed to our roadmap," said Enevate CEO Robert A. Rango. "We met a number of important milestones including ramping plans to significantly expand our pre-production manufacturing capability, securing additional investment, and expanding our hiring to bring in the best and brightest scientists, engineers and executives in the EV battery industry. As global auto markets pivot away from internal combustion engine vehicles to EVs, Enevate is well positioned to provide our pioneering EV battery technology to auto and battery manufacturers leading the global mobility revolution."
Here is a recap of several of Enevate’s most significant achievements:
Surpassed Major Milestone for Li-ion Battery Patents
Enevate reached a major milestone of 100 patents issued worldwide, and now has 117 patents and more than 380 additional patents in process, bringing the company’s total issued and in process patent portfolio at the close of 2021 to nearly 500. Enevate has more patent families directed to silicon battery technologies than all our competitors combined.
Secured $81M Series E funding Led by Fidelity Management & Research Company, Bringing Total Investment to Nearly $200 Million
That latest round, which included existing investors Mission Ventures and Infinite Potential Technologies, has enabled Enevate to begin ramping for a significant expansion of its pre-production line designed to guide EV and other battery customers toward implementing larger-scale battery manufacturing utilizing Enevate’s silicon anode-based batteries, and the hiring of additional personnel with an emphasis on scientists and engineers.
Signed Production License Agreement with South Korea’s EnerTech International
This production agreement represented a major milestone in Enevate’s technology roadmap with commercialization of Enevate’s silicon-dominant XFC-Energy® battery technology in the transportation, mobility and reserve power markets scheduled for 2022. EnerTech International is a leader in delivering lithium-ion cells and uses state-of-the-art manufacturing facilities to produce large format batteries in high demand by rapidly growing markets.
A Cleaner, More Environmentally Friendly Battery Technology
Enevate received third-party verification that its XFC-Energy battery technology may allow for up to 26 percent reduction of carbon dioxide (CO2) emissions for manufacturing of EV batteries compared to conventional lithium-ion EV batteries (21 percent for NCA and 26 percent for NMC cells [kg CO2 eq. cradle-to-gate, per 1 KWh cell capacity]).1 These results point to the potential to lower an EV’s carbon footprint at the start of life, which is significant because battery manufacturing is the highest contributor of CO2 emissions for the manufacturing of an EV.
Full Speed Ahead in 2022
Enevate’s patented XFC-Energy technology stands to be a game changer for the EV industry, providing a path to produce extreme fast-charge EV batteries at low cost and high-volume production. Enevate is currently working with multiple electric vehicle and battery manufacturers to commercialize its technology as early as 2022 in e-motorcycles and for the 2024-2025 automotive model years, utilizing existing manufacturing infrastructure with minimal investment required, a core goal of its development.
Enevate's technology transfer and intellectual property licensing business model is ideal for any company that operates or plans to operate battery manufacturing facilities. Enevate provides EV battery manufacturers with the ability to use existing manufacturing infrastructure with minimal additional investment, enabling an entirely new generation of EVs that will eliminate the customer pain points with EV ownership.
ABOUT ENEVATE (www.enevate.com)
Enevate develops and licenses advanced battery technology for electric vehicles (EVs), with a vision of EVs charging as fast as refueling gas cars, accessible and affordable to everyone, and accelerating EVs' mass adoption. With a portfolio of nearly 500 patents issued and in process, Enevate's pioneering advancements (leveraging accelerated battery testing and machine learning) in silicon-dominant anodes and cells have resulted in battery technology that features five-minute extreme fast charging with high energy density, low-temperature operation for cold climates, low cost and safety advantages over conventional batteries.
Enevate's vision is to develop and propagate EV battery technology that contributes to a clean and sustainable environment. The Irvine, California-based company's investors include Renault-Nissan-Mitsubishi (Alliance Ventures), LG Chem, Samsung Venture Investment Corp, Fidelity Management & Research Company, Mission Ventures, Draper Fisher Jurvetson, Tsing Capital, Infinite Potential Technologies, Presidio Ventures – a Sumitomo Corporation company, Lenovo, CEC Capital, and Bangchak. Enevate®, the Enevate logo, HD-Energy®, XFC-Energy® and eBoost® are registered trademarks of Enevate Corporation.
1 Enevate CO2 emissions information in accordance with international standards ISO 14044:2006, section 6.1 critical review. Further information available from Enevate Corp., 101 Theory # 200, Irvine, CA 92617.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211222005140/en/
Contacts
Bill Blanning
bblanning@enevate.com
+1 (714) 916-4309
(Bloomberg) — The queue of jumbo listings in Asia next year includes the world’s second-largest battery maker in Seoul and an insurer with more than 1.2 million agents and 100,000 employees in Mumbai. Mega deals from Chinese issuers in Hong Kong, meanwhile, may take a while to resume.Most Read from BloombergOmicron at Least Doubles Risk of Getting Infected on a PlaneFDA Expected to Authorize Pfizer and Merck Covid Pills This WeekOmicron Has 80% Lower Risk of Hospitalization, New Study ShowsIsra
What happened Chinese electric vehicle (EV) maker Nio (NYSE: NIO) held its annual Nio Day event last weekend where it unveiled its latest new electric sedan. Though customers appear to be eager to purchase one, Nio stock's continued decline has resulted in a 22% drop in the stock's value over the past month.
The last two days have been busy for Naked Brand Group. Today's decline is really just a technical issue. But there's a bigger story here.
The billionaire founder of the world's largest hedge fund says "cash is trash."
Stock buybacks continue at a record pace, powered by these 20 very large companies.
When stocks fall in price, it’s frequently a signal for renewed investor interest. After all, low share prices offer a chance to live up to the old market advice, ‘buy low and sell high.’ What investors need is some way to tell the underlying reasons for a drop in share price, whether it bodes well or ill for the stock. One of the best stock signals comes from corporate insiders, the company officers who hold positions of high responsibility – to their Boards, and to their peers, and to their sh
Electric vehicle start-up Rivian Automotive's (NASDAQ: RIVN) November debut on Wall Street was one of the most hyped initial public offerings in recent memory. Its market cap is already more than $80 billion, and shareholders are hoping it becomes the next Tesla (NASDAQ: TSLA). With high demand for its upcoming vehicles and a large deal to supply vans to Amazon, Rivian could be a long-term winner.
In this article, we discuss the 10 stocks that Israel Englander is buying. You can skip our detailed analysis of Englander’s hedge fund and recent developments, and go directly to read Billionaire Israel Englander is Buying These 5 Stocks. Israel Englander founded Millennium Management in 1989 with $35 million. The fund currently manages over $57 […]
Novavax Inc. shares were volatile in the extended session Wednesday after the biotech drug maker said initial data showed its COVID-19 vaccine booster showed immune responses against the omicron variant.
The Dow Jones Industrial Average turned lower Wednesday. Tesla stock jumped after Chief Executive Elon Musk said he had sold "enough stock."
Just because the market is falling doesn't mean the best place for your money is under the mattress.
The recent tech sell-off presents a great opportunity for investors to buy some quality stocks if you take a long-term approach.
Exxon Mobil Corporation (NYSE:XOM) still stands to benefit from a reopening economy, as well as a defense against rising oil prices due to inflation. Exxon also has a US$3.52 dividend per share, which amounts to a 5.8% yield. Today, we will evaluate the major fundamental aspects of the stock, as well as its dividend viability.
Viatris' (NASDAQ: VTRS) valuation is so low that I had to double-check the numbers. If Viatris chose to use its profits on stock buybacks, it could scoop up every outstanding share by mid-2025. Viatris' main priorities for using its capital are to pay down debt and to fund its dividend program.
Investors piled a record $900 billion into ETFs this year — nearly double what they invested in all of 2020. What are they so eager to buy?
Alexandra Ford English bought $750,000 of Ford Motor stock on Monday. She joined the company’s board of directors earlier this year.
Decreasing concerns about the omicron variant are leading to declining prices for these vaccine stocks.
The ARK Invest CEO argues that index funds are overvalued, while "stay at home" stocks are now trading at a discount.
Retail investors got news from the company that should have pleased them last week, but GameStop shares continue to slide.
Here's another cold, hard truth that many proponents of penny stocks don't tell you: Many low-priced shares stay low for a very long time.
